Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Does Renal Sympathetic Denervation Impact the Outcome in Sepsis-Induced Shock? An Experimental Porcine Model.

Journal of clinical medicine·2026
Same author

A Non-Interventional, Multicenter, Observational Study to Provide Real World Evidence on the Diagnosis of Chronic Coronary Syndrome In Patients With Diabetes Mellitus In Greece - The CONTACT STUDY.

Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese·2026
Same author

Beyond Single-Class Therapy: Real-World Combined Use of GLP-1 Receptor Agonists and SGLT2 Inhibitors in Type 2 Diabetes and Atherosclerotic Cardiovascular Disease.

Advances in therapy·2026
Same author

Computational intelligence using nailfold videocapillaroscopy for the prediction of carotid intima-media thickness in rheumatoid arthritis: a cohort-based study.

Rheumatology international·2026
Same author

Comparative Effects of SGLT2 Inhibitors and GLP-1 Receptor Agonists on Composite Surrogate Markers of Insulin Resistance: A Real-World Study Using METS-IR and SPISE.

Journal of clinical medicine·2026
Same author

Single Interventions (Pharmacological or Renal Denervation) Are Not Sufficient to Achieve Blood Pressure Control in Resistant Hypertension: A Systematic Review and Meta-Analysis.

Hypertension (Dallas, Tex. : 1979)·2026

Related Experiment Video

Updated: May 22, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
04:22

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

Antihypertensive treatment and sexual dysfunction.

Athanasios Manolis1, Michael Doumas

  • 1Cardiology Department, Asclepeion General Hospital, 41, Thassou Street, 16672, Athens, Greece. ajmanol@otenet.gr

Current Hypertension Reports
|May 15, 2012
PubMed
Summary

Antihypertensive medications can cause sexual dysfunction, with older drugs like diuretics and beta blockers being more problematic. Newer options and treatments like phosphodiesterase (PDE)-5 inhibitors offer better outcomes for hypertensive patients.

Related Experiment Videos

Last Updated: May 22, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
04:22

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

Area of Science:

  • Cardiovascular medicine
  • Pharmacology
  • Sexual health

Background:

  • Sexual dysfunction is common in patients with hypertension.
  • Antihypertensive therapy is hypothesized to contribute to sexual dysfunction.
  • Drug-specific effects on sexual function are suggested by existing evidence.

Purpose of the Study:

  • To review the impact of antihypertensive drugs on sexual function.
  • To compare the effects of different classes of antihypertensive medications.
  • To discuss the safety and efficacy of phosphodiesterase (PDE)-5 inhibitors in hypertensive patients.

Main Methods:

  • Literature review of studies on antihypertensive drugs and sexual dysfunction.
  • Analysis of clinical data regarding drug-induced sexual side effects.
  • Evaluation of treatment strategies for sexual dysfunction in hypertensive individuals.

Main Results:

  • Older antihypertensive drugs (diuretics, beta blockers) are associated with negative effects on erectile function.
  • Newer agents, including nebivolol and angiotensin receptor blockers, demonstrate neutral or beneficial effects on sexual function.
  • Phosphodiesterase (PDE)-5 inhibitors are effective and safe for treating sexual dysfunction in hypertensive patients, even with multiple medications.

Conclusions:

  • Drug selection is crucial for managing sexual dysfunction in hypertensive patients.
  • Newer antihypertensive medications offer improved sexual function outcomes.
  • Phosphodiesterase (PDE)-5 inhibitors represent a safe and effective treatment option for sexual dysfunction in this population.